Umbilical Deposit in Metastatic Breast Cancer
XJ01-XJ02
Correspondence
TM Anoop,
Associate Professor, Department of Medical Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India.
E-mail: dranooptm@yahoo.co.in
Sister Mary Joseph nodule or Sister Mary Joseph Sign refers to a palpable umbilical nodule as a result of metastasis from disseminated malignancy. It is a rare finding and is a sign of advanced stage of malignancy. Gastrointestinal malignancies and gynaecologic malignancies account for most cases of umbilical deposit. Here, the authors describe a case of disseminated metastatic breast cancer with umbilical metastases as Sister Mary Joseph nodule.
A 59-year-old postmenopausal lady presented with progressive abdominal distension and exertional breathlessness of two months duration. The patient had history of triple negative breast cancer treated in December 2017 with neoadjuvant chemotherapy, Modified Radical Mastectomy and adjuvant radiation. Clinical examination revealed enlarged right axillary lymph node, distended abdomen with pelvic mass, ascites and an infected pea sized umbilical lesion clinically suggestive of Sister Mary Joseph nodule (Table/Fig 1).
A Computer Tomography of abdomen and pelvis showed an umbilical deposit with size of 3.4×3.3 cm (Table/Fig 2) along with moderate ascites, multiple peritoneal and omental deposits. A bulky uterus with mass like enhancement in endometrial cavity and Peritoneal and Omental Deposits (POD) deposits were also noted. Metastatic evaluation with Computer Tomography of Chest, Abdomen and Pelvis also revealed mediastinal lymphadenopathy, lung and liver metastases. Right axillary lymph node biopsy showed metastatic adenocarcinoma. Immunohistochemistry revealed negative staining for estrogen, progesterone and Her 2/Neu receptors. Final diagnosis of disseminated metastatic breast cancer with umbilical deposit was considered.
Patient received palliative chemotherapy with single agent carboplatin for six cycles. Evaluation done 3 weeks after sixth cycle of palliative chemotherapy with CT scan, showed progressive increase in size of peritoneal deposits, ascites and lung metastasis. Patient opted for follow-up with supportive care thereafter. The first umbilical metastasis was described by Storer in 1864. Sir Hamilton Bailey coined the term “Sister Mary Joseph nodule” as this sign was first identified by Sister Mary Joseph who was a surgical assistant to Dr William James Mayo, in patients being prepared for surgery in 1928 (1).
The nodules are typically firm and irregular, located at dermal, subcutaneous or peritoneal level. They may be sometimes painful, ulcerate or fistulise, with a serous, purulent or bloody discharge. Commonly encountered primary tumours associated with umbilical metastasis include stomach, ovary, colorectal and pancreas (2). The presence of an umbilical metastasis indicates a poor prognosis and is a sign of disseminated malignancy (3). The differential diagnosis of umbilical nodule is Sister Mary Joseph nodule, umbilical granuloma, umbilical hernia, endometriosis, omphaliths and keloid (4). Sister Mary Joseph nodule is associated with evidence of disseminated malignancy especially with gastric and genitourinary malignancies [5,6].
Umbilical endometriosis usually occurs in reproductive age group with bleeding from umbilcal nodule during menstruation [7,8]. Omphaliths are formed due to poor personal hygiene which results in accumulation of sebum and exfoliated skin within the umbilicus (9). Umbilical keloids usually have a history of trauma or umbilical piercing (10). Umbilical hernia may be congenital or postsurgical in origin.
This article highlights the importance of keeping Sister Mary Joseph nodule in the differential diagnoses for umbilical hernia. Though rare, breast metastasis may present as umbilical hernia.